KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Short term Debt (2019 - 2025)

GoodRx Holdings' Short term Debt history spans 7 years, with the latest figure at $5.0 million for Q4 2025.

  • For Q4 2025, Short term Debt changed 0.0% year-over-year to $5.0 million; the TTM value through Dec 2025 reached $5.0 million, changed 0.0%, while the annual FY2025 figure was $5.0 million, 0.0% changed from the prior year.
  • Short term Debt for Q4 2025 was $5.0 million at GoodRx Holdings, roughly flat from $5.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $8.8 million in Q4 2023 and bottomed at $3.8 million in Q3 2024.
  • The 5-year median for Short term Debt is $7.0 million (2021), against an average of $6.4 million.
  • The largest annual shift saw Short term Debt tumbled 46.65% in 2024 before it surged 33.33% in 2025.
  • A 5-year view of Short term Debt shows it stood at $7.0 million in 2021, then changed by 0.0% to $7.0 million in 2022, then increased by 25.01% to $8.8 million in 2023, then crashed by 43.1% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Short term Debt are $5.0 million (Q4 2025), $5.0 million (Q3 2025), and $5.0 million (Q2 2025).